Listen to The Lancet Gastroenterology & Hepatology
Science & Medicine
Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.
More Episodes
In conversation with... Arndt Vogel
2024-07-31
2024-07-31
In conversation with... Nuru Noor
2024-05-09
2024-05-09
In conversation with... Mads Israelsen
2024-03-12
2024-03-12
In conversation with... Louise Dye
2024-03-01
2024-03-01
In conversation with... Tzu-Chan Hong
2023-12-20
2023-12-20
In conversation with... Sarah Moen
2023-11-28
2023-11-28
In conversation with... Anna Emilie Kann
2023-10-14
2023-10-14
In conversation with... Robert Krouse
2023-09-13
2023-09-13
In conversation with... Marc Rothenberg
2023-08-10
2023-08-10
In conversation with... Jasmohan Bajaj
2023-06-07
2023-06-07
In conversation with... Adelina Artenie
2023-05-11
2023-05-11
In conversation with... Johan Burisch
2023-04-13
2023-04-13
In conversation with... Edouard Louis
2023-02-09
2023-02-09
In conversation with... Paula Ghaneh
2023-01-24
2023-01-24
In conversation with... Dan Turner
2023-01-07
2023-01-07
In conversation with... Simon Baunwall
2022-11-10
2022-11-10
In conversation with... James Alexander
2022-10-06
2022-10-06
Get this podcast on your
phone, FREE
